Probenecid, a gout remedy, inhibits pannexin 1 channels

Am J Physiol Cell Physiol. 2008 Sep;295(3):C761-7. doi: 10.1152/ajpcell.00227.2008. Epub 2008 Jul 2.

Abstract

Probenecid is a well-established drug for the treatment of gout and is thought to act on an organic anion transporter, thereby affecting uric acid excretion in the kidney by blocking urate reuptake. Probenecid also has been shown to affect ATP release, leading to the suggestion that ATP release involves an organic anion transporter. Other pharmacological evidence and the observation of dye uptake, however, suggest that the nonvesicular release of ATP is mediated by large membrane channels, with pannexin 1 being a prominent candidate. In the present study we show that probenecid inhibited currents mediated by pannexin 1 channels in the same concentration range as observed for inhibition of transport processes. Probenecid did not affect channels formed by connexins. Thus probenecid allows for discrimination between channels formed by connexins and pannexins.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Triphosphate / metabolism*
  • Animals
  • Connexins / antagonists & inhibitors
  • Connexins / metabolism
  • Dose-Response Relationship, Drug
  • Gap Junction beta-1 Protein
  • Gout Suppressants / pharmacology*
  • Ion Channels / antagonists & inhibitors*
  • Ion Channels / genetics
  • Ion Channels / metabolism
  • Membrane Potentials
  • Nitrobenzoates / pharmacology
  • Oocytes
  • Probenecid / pharmacology*
  • Xenopus laevis

Substances

  • Connexins
  • Gout Suppressants
  • Ion Channels
  • Nitrobenzoates
  • GJA3 protein, human
  • 5-nitro-2-(3-phenylpropylamino)benzoic acid
  • Adenosine Triphosphate
  • Probenecid